Tiker4's total market worth is $2.38B along with 167.25M outstanding shares. Bojangles Inc (NASDAQ:BOJA) has risen 4.24% since October 14, 2016 and is uptrending. It has underperformed by 5.55% the S&P500. Strategic Advsr Limited Company invested 1.54% of its portfolio in AbbVie Inc (NYSE:ABBV). Navellier & Associates Inc now owns 32,755 shares of the company's stock valued at $2,134,000 after buying an additional 4,928 shares in the last quarter. Tiemann Invest Advsrs Ltd Limited Liability Company invested in 1.11% or 17,056 shares. Carret Asset Management Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $144.54 billion market cap company. Stockholders of record on Friday, October 13th will be given a dividend of $0.64 per share. The company had a trading volume of 6,803,873 shares. On October 2 the company was upgraded from "Market Perform" to "Outperform" with a current price target of $106.00 in a report from Leerink Swann. It has underperformed by 6.07% the S&P500. Its quick ratio for most recent quarter is 2.40 along with current ratio for most recent quarter of 2.40. The ex-dividend date is Thursday, October 12th.
Clear Harbor Asset Management Llc decreased Scorpio Tankers Inc (STNG) stake by 64.01% reported in 2017Q2 SEC filing. The company presently has an average rating of "Buy" and an average price target of $85.60. Cambrex Corp had 5 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained Bojangles Inc (NASDAQ:BOJA) on Tuesday, August 9 with "Buy" rating. (NASDAQ:VIAB) on Monday, July 11 to "Underperform" rating. Jefferies has "Buy" rating and $600 target. The rating was downgraded by Credit Suisse to "Neutral" on Monday, October 31. The rating was upgraded by TheStreet to "Buy" on Tuesday, August 11. The firm has "Buy" rating by SunTrust given on Wednesday, July 22. The stock of ImmunoGen, Inc. The company was upgraded on Wednesday, October 11 by Cowen & Co. The firm earned "Hold" rating on Monday, November 14 by Brean Capital. As per Tuesday, May 30, the company rating was maintained by Cantor Fitzgerald. Accident Compensation Corp increased its position in AbbVie by 24.7% in the 1st quarter. Its up 0.01, from 0.99 in 2017Q1. It increased, as 12 investors sold IMGN shares while 39 reduced holdings. 138,032 were reported by Federated Invsts Pa. Stifel Fincl reported 0% in ImmunoGen, Inc. (NASDAQ:VIAB) to report earnings on November, 8. Following the acquisition, the director now owns 15,498 shares in the company, valued at approximately $1,091,834.10. Victory Mgmt Incorporated, Ohio-based fund reported 172,980 shares. 4,641 were accumulated by Alpha Windward Limited Liability. State Board Of Administration Of Florida Retirement has 93,560 shares for 0% of their portfolio. Connecticut-based Aqr Mngmt Limited Liability Co has invested 0% in ImmunoGen, Inc. Gateway Invest Advisers Ltd Liability Com invested in 0.88% or 1.53M shares. (NASDAQ:IMGN). Axa invested 0.01% in ImmunoGen, Inc. Gfs Lc holds 11,248 shares or 0.18% of its portfolio. Pennsylvania-based Pnc Financial Gp has invested 0% in Cambrex Corporation (NYSE:CBM). Holderness Investments accumulated 14,188 shares.
Since May 4, 2017, it had 0 insider buys, and 5 selling transactions for $18.84 million activity.
In related news, CEO Richard A. Gonzalez sold 65,861 shares of the business's stock in a transaction dated Thursday, August 3rd. Schumacher Laura J sold 79,800 shares worth $5.59M. BMO Capital Markets reissued a "hold" rating and issued a $63.00 price target on shares of AbbVie in a report on Tuesday, April 18th. Therefore 52% are positive. Abbvie Inc had 62 analyst reports since July 21, 2015 according to SRatingsIntel. It shows the cash a company is able to generate after spending the money need to maintain or grow its asset base. AbbVie Inc. (ABBV) recently closed with rise of 4.61% to its 20-Day Simple Moving Average. The stock has "Outperform" rating by William Blair on Friday, February 5. The stock of AbbVie Inc (NYSE:ABBV) earned "Neutral" rating by UBS on Monday, September 25. Morgan Stanley downgraded the stock to "Equal-Weight" rating in Wednesday, June 8 report. 20,000 are held by Barbara Oil Co. The rating was maintained by BMO Capital Markets with "Hold" on Friday, April 28. The stock of Bojangles Inc (NASDAQ:BOJA) earned "Overweight" rating by KeyBanc Capital Markets on Monday, September 26. Jefferies has "Buy" rating and $10 target. Investor speculation and demand also help increase a share's price over time. Its down 0.60, from 1.59 in 2017Q1.
Several other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of AbbVie by 3.3% in the second quarter. Intrust National Bank & Trust Na stated it has 0.39% in AbbVie Inc (NYSE:ABBV). $2.50M worth of AbbVie Inc (NYSE:ABBV) was sold by CHASE WILLIAM J. 10,417 were accumulated by Interocean Llc. Bellecapital Intl Ltd holds 9,416 shares or 0.6% of its portfolio.
Trust Department MB Financial Bank N A decreased its stake in shares of AbbVie Inc (NYSE:ABBV) by 0.9% during the first quarter, Holdings Channel reports. 35,081 were reported by Advisor Prtnrs Ltd. Cantab Partners Limited Liability Partnership reported 0% of its portfolio in AbbVie Inc (NYSE:ABBV). 113,129 were reported by Ashfield Cap Prns. Lathrop Invest Mgmt Corporation reported 0.11% of its portfolio in AbbVie Inc (NYSE:ABBV). Fulton Natl Bank Na reported 0.46% stake. The High end of the forecast is $1.58 per share, while the Low end is $1.36 per share. Capital Research Global Investors now owns 178,274,835 shares of the company's stock valued at $12,926,708,000 after purchasing an additional 2,130,919 shares during the period.